It requires you to do some work beyond medication
DPP-4 inhibitors are also used therapeutically to enhance endogenous GLP-1 activity, but only for glycemic control, as they are weight-neutral
You may also reply HELP for additional assistance
In the SURMOUNT-1 trial, which evaluated tirzepatide for chronic weight management in adults without diabetes, approximately 67% of participants were women
GLP-1 Medications for Weight Loss: Semaglutide, Tirzepatide, and Retatrutide Compared The landscape of obesity treatment has shifted dramatically over the past decade, thanks to a class of medications known as GLP-1 receptor agonists
However, HbA1c did not differ between groups